State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Institute of Stem Cells, Beijing Health-Biotech Biotechnology Co. Ltd, Beijing, 100176, China.
Biochem Biophys Res Commun. 2021 Jan 1;534:149-156. doi: 10.1016/j.bbrc.2020.12.012. Epub 2020 Dec 11.
Natural killer (NK) cells are pivotal effector lymphocytes characterized for the innate immune response to pathogenic microorganism and tumor cells without priming and sensitization. Despite emerging knowledge has highlighted the rosy prospects in tumor immunosurveillance, yet the large-scale clinical application of NK cell-based therapy is hindered largely attributes to the defects in generating sufficient and high-quality cellular products. Herein, on the basis of 16 kinds of candidate combinations, we investigated the feasibility of cytokine cocktail-based strategy for convenient and standardized NK cell cultivation as well as the multifaceted characteristics and cytotoxicity against tumor cells. Our results revealed that joint utilization of Interleukin (IL)-2, IL-15, IL-18 manifested the optimal facilitation upon the ex vivo expansion and proportion of NK cells in peripheral blood mononuclear cells (PBMCs). Meanwhile, the obtained NK cell population expressed high levels of activating molecules (CD16 and NKG2D) and exhibited splendid cytotoxicity against K562 cell line. Collectively, with the aid of cytokine-based programming, we established an alternative strategy for facilitating the large-scale persistence and activation of NK cells from peripheral blood, which would benefit the NK cell- and chimeric antigen receptor-modified NK (CAR-NK) cell-based autologous or allogeneic tumor immunotherapy.
自然杀伤 (NK) 细胞是先天免疫反应的关键效应淋巴细胞,能够识别病原体微生物和肿瘤细胞,而无需预先致敏。尽管新的研究进展强调了肿瘤免疫监视的广阔前景,但 NK 细胞为基础的治疗的大规模临床应用在很大程度上受到产生足够数量和高质量细胞产品的缺陷的阻碍。在此基础上,我们在 16 种候选组合的基础上,研究了基于细胞因子鸡尾酒的策略在方便和标准化 NK 细胞培养方面的可行性,以及对肿瘤细胞的多方面特性和细胞毒性。我们的结果表明,白细胞介素 (IL)-2、IL-15 和 IL-18 的联合使用对体外扩增和外周血单个核细胞 (PBMCs) 中 NK 细胞的比例具有最佳的促进作用。同时,获得的 NK 细胞群体表达高水平的激活分子 (CD16 和 NKG2D),并对 K562 细胞系表现出极好的细胞毒性。总之,通过基于细胞因子的编程,我们建立了一种促进外周血 NK 细胞大规模持久和激活的替代策略,这将有利于 NK 细胞和嵌合抗原受体修饰的 NK (CAR-NK) 细胞的自体或同种异体肿瘤免疫治疗。